Twist Bioscience Corp (TWST) › Cash & EquivalentsTwist Bioscience Corp (TWST) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2017: $31.23M2018: $80.76M2019: $46.73M2020: $93.67M2021: $465.83M2022: $378.69M2023: $286.47M2024: $226.32M2025: $183.05M$183.05M2017Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$183.05M-19.1%2024$226.32M-21.0%2023$286.47M-24.4%2022$378.69M-18.7%2021$465.83M+397.3%2020$93.67M+100.4%2019$46.73M-42.1%2018$80.76M+158.6%2017$31.23M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share